Substituted pyrazole compound
PK141181AUndetermined Publication Date: 2011-04-30AVENTLS PHARMACEUTICALS INC
0 Cites 0 Cited by
Patent Information
- Application Number
- PK200400322
- Authority / Receiving Office
- PK · PK
- Patent Type
- Applications
- Current Assignee / Owner
- Publication Date
- 2011-04-30
Abstract
The present invention provides compound of Formula (I) pharmaceutical composition comprising such compound, and their pharmaceutical use in the treatment of disease status capable of being modulated by the inhibition of p38 kinase and / or tumor necrosis factor (TNF).
Need to check novelty before this filing date? Find Prior Art